Stock market today: Wall Street gains ground after shaking off four-week losing streak
Stocks rose in morning trading as Wall Street navigates through uncertainty amid a trade war. The S&P 500 jumped 1.1%. It is ...
Zacks Investment Research on MSN7h
Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?
Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...
China Highlights Business Opportunities to America’s Apple (AAPL) and Pfizer
China is making efforts to highlight the country’s business opportunities to major American corporations like Apple (AAPL), ...
Is Pfizer Inc. (PFE) The Best Healthcare Dividend Stock to Invest in?
We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...
Notable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focus
Discover the top gainers and losers in the S&P 500 Healthcare Index and stay updated on major news like J&J's $55B investment and Pfizer's Haleon stake exit.
Pfizer: Bulls Need To Check Out Its Graham P/E
Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...
Looking For Yields: Pfizer, Spire, And TriCo Bancshares Are Consistent Moneymakers
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.